Poly[allylamine hydrochloride] (RenaGel): a noncalcemic phosphate binder for the treatment of hyperphosphatemia in chronic renal failure.

[1]  E. Slatopolsky,et al.  RenaGel, a novel calcium- and aluminium-free phosphate binder, inhibits phosphate absorption in normal volunteers. , 1997, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[2]  A. Dusso,et al.  Phosphorus restriction prevents parathyroid gland growth. High phosphorus directly stimulates PTH secretion in vitro. , 1996, The Journal of clinical investigation.

[3]  S. Grundy,et al.  Mechanisms and treatment of dyslipidemia of renal diseases. , 1993, Current opinion in nephrology and hypertension.

[4]  J. Bourdeau,et al.  Calcium and phosphorus fluxes during hemodialysis with low calcium dialysate. , 1991, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[5]  M. Bia,et al.  Etiology of hypercalcemia in hemodialysis patients on calcium carbonate therapy. , 1990, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[6]  A. Dusso,et al.  Phosphorus restriction reverses hyperparathyroidism in uremia independent of changes in calcium and calcitriol. , 1990, The American journal of physiology.

[7]  E G Lowrie,et al.  Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities. , 1990, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[8]  J. Delmez,et al.  Long-term effects of calcium carbonate and 2.5 mEq/liter calcium dialysate on mineral metabolism. , 1989, Kidney international.

[9]  K. Schaefer,et al.  Calcium salts of ketoacids as a new treatment strategy for uremic hyperphosphatemia. , 1989, Kidney international. Supplement.

[10]  L. Schiller,et al.  Calcium acetate, an effective phosphorus binder in patients with renal failure. , 1989, Kidney international.

[11]  J. Hamer,et al.  FAT EMBOLISM AND PATENT FORAMEN OVALE , 1989, The Lancet.

[12]  J. Delmez,et al.  Calcium carbonate as a phosphate binder in patients with chronic renal failure undergoing dialysis. , 1986, The New England journal of medicine.

[13]  B. Lacour,et al.  Effect of aluminum on hematopoiesis. , 1986, Kidney international. Supplement.

[14]  W. Goodman,et al.  Bone disease and aluminum: pathogenic considerations. , 1985, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[15]  A. Arieff.  Aluminum and the pathogenesis of dialysis encephalopathy. , 1985, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[16]  M. Gonella,et al.  Effects of high CaCO3 supplements on serum calcium and phosphorus in patients on regular hemodialysis treatment. , 1985, Clinical nephrology.

[17]  R. Morris,et al.  Effect of dietary phosphorus on circulating concentrations of 1,25-dihydroxyvitamin D and immunoreactive parathyroid hormone in children with moderate renal insufficiency. , 1984, The Journal of clinical investigation.

[18]  J. Ohls,et al.  The validity of a telephone-administered 24-hour dietary recall methodology. , 1982, The American journal of clinical nutrition.

[19]  H. Harter,et al.  Minerals, vitamin D, and parathyroid hormone in continuous ambulatory peritoneal dialysis. , 1982, Kidney international.

[20]  W. D. Kaehny,et al.  Gastrointestinal absorption of aluminum from aluminum-containing antacids. , 1977, The New England journal of medicine.

[21]  E. Slatopolsky,et al.  The role of phosphorus restriction in the prevention of secondary hyperparathyroidism in chronic renal disease. , 1973, Kidney international.

[22]  A. Katz,et al.  HYPERCALCÆMIA AFTER ORAL CALCIUM-CARBONATE THERAPY IN PATIENTS ON CHRONIC HÆMODIALYSIS , 1973 .

[23]  J. Pennell,et al.  On the pathogenesis of hyperparathyroidism in chronic experimental renal insufficiency in the dog. , 1971, The Journal of clinical investigation.

[24]  C. Combe,et al.  In advanced renal failure, dietary phosphorus restriction reverses hyperparathyroidism independent of changes in the levels of calcitriol. , 1993, Nephron.

[25]  R. Brown,et al.  1,25-dihydroxycholecalciferol and parathyroid hormone in advanced chronic renal failure: effects of simultaneous protein and phosphorus restriction. , 1986, Clinical nephrology.

[26]  B. S. Burke.  The dietary history as a tool in research , 1947 .